|
|
 |
|
Viewing report
|
|
|
|
Update: Pharmaceutical Pricing Strategies 2000: Entering the new millennium
Business Insights, June 2000
The favorable climate of the pharmaceutical sector has changed radically over the past ten years where once a company''s freedom over pricing decisions was almost limitless, external pressures such as cost-containment now restrict the industry''s revenue opportunities. Therefore, the pressure on pharmaceutical companies to develop new strategies to maintain and justify the premium pricing of a product is immense. Consequently, it is more vital than ever before that players truly understand the changing healthcare landscape.
Customers who bought this item also bought
Outcomes-Based Pharmaceutical Pricing
Pharmaceutical Pricing and Reimbursement: Strategies for Market Access Across the US, Europe, Japan and Other Key Geographies
Pharmaceutical Pricing and Reimbursement in the United Kingdom, 2008
Pharmaceutical Pricing and Reimbursement in China
Pharmaceutical Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the First Quarter of 2008
Special Report: Pharmaceutical Pricing and Reimbursement in Germany, 2008
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2007
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Third Quarter of 2007
Valuing Pharmaceutical Innovation: Pricing and Reimbursement for Innovative Therapies
Pharmaceutical Pricing and Reimbursement in Japan
Pharmaceutical Pricing Strategies: Optimizing Returns Throughout R&D And Marketing
|
|
|
|
